Tag - pharmaceuticals

 
Menu
Search
 
May 17, 2024
 

Today's print edition

Home Delivery
Subscribe for more access

PHARMACEUTICALS

Japan Times
BUSINESS
Jul 1, 2020
Fujifilm ties up with Indian firm on potential COVID-19 drug Avigan
The drug has yet to be approved by the Japanese government for coronavirus treatment, with clinical testing delayed due to insufficient enrollment.
Japan Times
JAPAN / Science & Health
Jun 24, 2020
Wanted: More COVID-19 patients in Japan ... for clinical trials
Japan has become a victim of its own success as slowing new infections have led to a shortage of patients to enroll in trials for treatments and vaccines.
JAPAN / Science & Health
Jun 23, 2020
Osaka's Rohto to begin stem cell clinical trial for COVID-19 in August
Rohto Pharmaceutical Co. said Tuesday it will begin a clinical trial in August using stem cells for a potential treatment for patients severely ill with COVID-19.
Japan Times
BUSINESS / Companies
Jun 23, 2020
Gilead targets remdesivir supply for 2 million COVID-19 patients by year-end
The company also said it hoped to start trials in August of an easier-to-use inhaled version of the medicine, which is currently administered only intravenously.
Japan Times
BUSINESS / Companies
Jun 22, 2020
Japan drugmaker to tie up with universities to develop new test method for coronavirus
Japanese pharmaceutical company Shionogi & Co. said Monday that it will collaborate with universities in the country to put into practical use a new testing method for the novel coronavirus.
Japan Times
JAPAN / Science & Health
Jun 12, 2020
Daiichi Sankyo sees clinical test for genetic COVID-19 vaccine in March
The vaccine contains messenger RNA that causes cells to produce proteins that could trigger the body to produce effective antibodies.
JAPAN / Science & Health
Jun 11, 2020
Drugmaker eyes stem cell clinical test for coronavirus treatment
Japanese drugmaker Rohto Pharmaceutical Co. said Thursday it plans to launch a clinical trial using stem cells to develop a treatment for severe cases of COVID-19, the respiratory illness caused by the novel coronavirus.
Japan Times
BUSINESS / Markets
Jun 8, 2020
Chugai stock surges 60% to rival Sony's value on hopes for virus treatment
Chugai Pharmaceutical is now Japan's biggest drug company by market value after overtaking Daiichi Sankyo and Takeda Pharmaceutical.
Japan Times
BUSINESS
Jun 7, 2020
Fujifilm's COVID-19 drug research will drag on into July, source says
The recent fall in the number of confirmed infections has made it difficult to reach the enrollment target of 96 patients.
Japan Times
WORLD / Science & Health
Jun 2, 2020
Scientists hunt pandemic hot spots in race to test vaccines
The first wave of the COVID-19 pandemic may be waning. For vaccine developers, that could be a problem.
Japan Times
WORLD / Science & Health
Jun 1, 2020
After fast-tracking Japanese COVID-19 drug, Russia to roll out 'game changer' next week
Russia will start administering its first approved antiviral drug to treat coronavirus patients next week, its state financial backer told Reuters, a move it described as "a game changer" that should speed a return to normal economic life.
Japan Times
BUSINESS / Markets
May 26, 2020
Japan’s AnGes continues surge as coronavirus vaccine candidate moves closer to human trials
The progress of its drug development has led to wild swings in the stock, with shares falling more than 50 percent in two trading sessions earlier this month.
Japan Times
WORLD / Science & Health
May 23, 2020
Gilead’s remdesivir mainly helped healthier COVID-19 patients
Gilead Sciences Inc.’s remdesivir, the first medicine cleared for the treatment of COVID-19, mainly benefited healthier patients who weren’t dependent on ventilators or heart-lung bypass machines, according to published results of the study used to get the medicine on the market.
Japan Times
BUSINESS
May 22, 2020
Fujifilm plans to make flu drug Avigan available for 2 million people by March 2021
Fujifilm Holdings Corp. said Friday it is on course to supply the flu drug Avigan for 2 million COVID-19 patients by next March, meeting a target set by the government to ramp up production of the potential but yet unapproved coronavirus treatment.
Japan Times
JAPAN / Science & Health
May 22, 2020
Japan to subsidize mass production of eventual coronavirus vaccine
More than 110 coronavirus vaccine development projects are underway worldwide, with some in the clinical testing phase, according to a WHO list.
Japan Times
BUSINESS
May 21, 2020
Fukuoka startup to tap RNA tech for inhalable COVID-19 treatment
A biotechnology startup in Fukuoka Prefecture is partnering with local authorities to develop a drug to treat COVID-19 using its RNA technology.
Japan Times
BUSINESS
May 21, 2020
No pause in coronavirus trial for Avigan, Japan's lead researcher says
The lead researcher in the coronavirus trial for flu drug Avigan says it’s too early to make a call on whether it works and shrugged off negative reports about the interim results, saying patients are still being enrolled.
Japan Times
JAPAN / Science & Health
May 20, 2020
Drug Avigan that was pushed by Abe falls short in COVID-19 trials
The lack of results have raised doubts about its approval by the end of this month, as sought by the government.
Japan Times
COMMENTARY / World
May 19, 2020
Vaccine developers need to take their time
Positive study results have arrived quickly, but the next steps will be slower.
Japan Times
WORLD
May 19, 2020
Trump says he’s taking anti-malaria drug that led to FDA warning
Trump is a self-admitted germophobe, telling reporters he was wary of shaking hands even before the coronavirus pandemic.
Japanese stripper bids to have her porn movies taken off internet
Plaintiff Miyuki Ariga (left) speaks at a news conference along with her lawyer, Yoshitomo Morohashi, after filing a lawsuit at the Tokyo District Court on Monday.
Kishida defends planned rule to revoke foreigners' residency
Prime Minister Fumio Kishida speaks during a meeting of the Lower House Judicial Affairs Committee on Wednesday.
Human bone-like objects found at Nippon Steel plant’s molten iron pot, with one worker missing
Police believe it’s highly possible that human bones found in a molten iron pot at Nippon Steel's Oita factory belong to a missing male employee.
Was Onosato's defeat of Terunofuji an era-defining bout?
Onosato (right) defeats Terunofuji at the Ryogoku Kokugikan in Tokyo on May 12. While nothing in sumo is guaranteed, it seems almost inevitable that Onosato is destined for the top of the sport's pyramid.
Man suspected of using smart glasses to cheat on Waseda University exams
The Waseda University campus in Tokyo. An 18-year-old male test-taker is suspected of using smart glasses to cheat during the university's entrance exam.
Japanese billionaire sues Meta over investment scams using his image
Entrepreneurs Yusaku Maezawa (second from right) and Takafumi Horie (third from right) attend a study session on fake social media ads and investment scams at the Liberal Democratic Party headquarters in Tokyo on April 10.
Japanese rap creates its mecca in Pop Yours
Tokyo-based artist Jumadiba says he forgoes the label of simply “rap” for his music because the Japanese rap scene isn’t confined to a particular sound.
Who’s toughest on China? Biden’s tariff tactic ups ante as election looms.
U.S. President Joe Biden speaks about new actions to protect American workers and businesses from China's "unfair" trade practices, in the Rose Garden of the White House in Washington on Tuesday.
Was Onosato's defeat of Terunofuji an era-defining bout?
Onosato (right) defeats Terunofuji at the Ryogoku Kokugikan in Tokyo on May 12. While nothing in sumo is guaranteed, it seems almost inevitable that Onosato is destined for the top of the sport's pyramid.
Ishin struggles to set itself apart from other parties
Nippon Ishin no Kai Secretary-General Fumitake Fujita (right) speaks beside Yui Kanazawa, the party's candidate in the Tokyo 15th district by-election on April 28. Nippon Ishin lost in this by-election as well as another in Nagasaki held on the same day.

Podcast

From easily navigable train stations to the helpfulness of its municipal staff, Tokyo has earned high praise for its commitment to accessibility for disabled travelers.
[Rebroadcast] Japan is doing better on accessibility than you may think

Longform

Things may look perfect to the outside world, but today's mom is fine with some imperfection at home.
How 'Reiwa moms' are reshaping motherhood in Japan
By Mai Yoshikawa

SUSTAINABLE JAPAN

Vol. 35: Travel in time — and stay there
Vol. 35: Travel in time — and stay there

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER